| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3029866 | Thrombosis Research | 2008 | 7 Pages |
Abstract
This study demonstrates the potential of employing hs-IL-6 as an early stage biomarker for the prognosis of acute ischemic stroke. Such an advance would provide the means to identify at an early stage the patients who would require closer clinical surveillance and/or administration of therapeutic interventions.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shani Shenhar-Tsarfaty, Einor Ben Assayag, Irena Bova, Ludmila Shopin, Shlomo Berliner, Itzhak Shapira, Natan M. Bornstein,